Pure Global

Insulin syringe, fixed-needle - ARTG 443674

Access comprehensive regulatory information for Insulin syringe, fixed-needle in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 443674 and sponsored by Avaderm Pty Ltd, manufactured by Feel Tech Bio Co Ltd in South Korea. The device registration started on March 13, 2024.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class IIa
ARTG 443674
Class IIa
Insulin syringe, fixed-needle
ARTG ID: 443674
Good Name: Avaderm Pty Ltd - Insulin syringe, fixed-needle
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

This device is intended for subcutaneous injection of insulin. This device is single-use.

Device Classification
Risk Class
Class IIa
Product Type
Single Device Product
ARTG Category
General
Registration Information
ARTG ID
443674
Start Date
March 13, 2024
Effective Date
March 13, 2024
Sponsor
Manufacturer
Country
South Korea
Address
1079-20 Charyeonggogae-ro Gwangdoek-myeon Cheonan-si, Dongnam-gu, Chungcheongnam-do, 31223